Skip to main content
Recall Canary
Semaglutide-Glycine-Cyanocobalamin Injectable
← Back to all recalls
DRUG RECALLMODERATE

Semaglutide-Glycine-Cyanocobalamin Injectable

Northwest Compounders is recalling Semaglutide-Glycine-Cyanocobalamin Injectable vials due to lack of assurance of sterility.

What to do

Do not use this medication. Contact your pharmacy or healthcare provider immediately for a replacement or alternative treatment. Return the product to your pharmacy.

Posted
Updated
Recall No.
D-0471-2026
Agency
Firm
PAYLESS COMPOUNDERS, LLC
Recall ID
98646
Status
ONGOING

Why it was recalled

Lack of Assurance of Sterility

How to identify it

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Where it was sold

Distributed in US-OR.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification